GSK gives up on rare diseases as gene therapy gets two customers – Reuters
Reuters |
GSK gives up on rare diseases as gene therapy gets two customers
Reuters LONDON (Reuters) – GlaxoSmithKline is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire see the field as a rich seam for profits. Successful medicines for rare conditions are … |
